Answers are grounded in this paper and cite their sources.
Hypertension concomitant with coronary heart disease, as a prevalent cardiovascular ailment in clinical practice, has long garnered considerable attention in its treatment. In recent years, an integrative approach combining both traditional Chinese and Western medicine, guided by the principle of personalized targeting, has exhibited notable advantages and potential in the prevention and treatment of hypertension complicated by coronary heart disease. This discourse aims to explore the application of integrative Chinese and Western medical strategies guided by the principle of personalized targeting in the prevention and treatment of hypertension concomitant with coronary heart disease. The principle of personalized targeting represents a burgeoning therapeutic paradigm, meticulously targeting the specific etiology or mechanisms of the disease, precisely selecting therapeutic targets, and dynamically adjusting treatment regimens throughout the course of treatment to achieve optimal therapeutic outcomes. In the treatment of hypertension complicated by coronary heart disease, the principle of personalized targeting holds significant applicability. The integrative approach of Chinese and Western medicine guided by the principle of personalized targeting offers a fresh perspective and methodology for the prevention and treatment of hypertension concomitant with coronary heart disease. It represents a feasible, effective therapeutic model poised to deliver enhanced clinical efficacy and quality of life for a vast number of patients.
No takes yet. Share an insight, caveat, or question.
Du et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: